"Investigators in The Cancer Genome Atlas (TCGA) Research Network have uncovered a connection between how tumor cells use energy from metabolic processes and the aggressiveness of the most common form of kidney cancer, clear cell renal cell carcin"...
- Patient Information:
Details with Side Effects
There is no specific treatment for TORISEL intravenous overdose. TORISEL has been administered to patients with cancer in phase 1 and 2 trials with repeated intravenous doses as high as 220 mg/m². The risk of several serious adverse events, including thrombosis, bowel perforation, interstitial lung disease (ILD), seizure, and psychosis, is increased with doses of TORISEL greater than 25 mg.
TORISEL is contraindicated in patients with bilirubin > 1.5×ULN [see WARNINGS AND PRECAUTIONS].
Last reviewed on RxList: 4/18/2014
This monograph has been modified to include the generic and brand name in many instances.
Additional Torisel Information
Torisel - User Reviews
Torisel User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
Find out what women really need.